Razobazam
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 3,8-dimethyl- 4-phenyl- 2,8-dihydropyrazolo [3,4-b][1,4]diazepine- 5,7(4H,6H)- dione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 78466-98-5 |
| ATC code | None |
| PubChem | CID 71228 |
| UNII | LZ84VWN0U4  |
| Chemical data | |
| Formula | C14H14N4O2 |
| Mol. mass | 270.28 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
|
Razobazam (INN) is a drug which is a benzodiazepine derivative. Its mechanism of action appears to be quite different from that of most benzodiazepine drugs, and it produces nootropic effects in animal studies.[1]
[edit] See also
[edit] References
- ^ Hock FJ, Scheich H. Functional activity in the brain of socially deprivated rats produced by an active avoidance test after razobazam (Hoe 175) treatment: a 2-deoxyglucose study. Behavioural and Neural Biology. 1986 Nov;46(3):398-409. PMID 3814045
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
